Flagship Biosciences was created by industry leading molecular pathologists to fill the growing need for advanced digital technology in drug development and medical devices. Our pathologists deliver quantitative results so our customers can make efficacy and toxicology assessments faster. We help our clients in many ways: Develop histology and IHC biomarkers Quantitate efficacy and toxicity tissue assays Increase visibility between study sponsors and their CROs Facilitate partnerships in clinical development